In August, President Biden signed the Inflation Reduction Act of 2022 (IRA) into law, and it could alter far more than the price of Medicare's most-prescribed drugs. Industry observers say it could affect the direction of research and some fear it may lead to further government forays into price control.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,